Log in to save to my catalogue

Oral Immunization with Recombinant ISaccharomyces cerevisiae/I Expressing Viral Capsid Protein 2 of...

Oral Immunization with Recombinant ISaccharomyces cerevisiae/I Expressing Viral Capsid Protein 2 of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A779344915

Oral Immunization with Recombinant ISaccharomyces cerevisiae/I Expressing Viral Capsid Protein 2 of Infectious Bursal Disease Virus Induces Unique Specific Antibodies and Protective Immunity

About this item

Full title

Oral Immunization with Recombinant ISaccharomyces cerevisiae/I Expressing Viral Capsid Protein 2 of Infectious Bursal Disease Virus Induces Unique Specific Antibodies and Protective Immunity

Publisher

MDPI AG

Journal title

Vaccines (Basel), 2023-12, Vol.11 (12)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Infectious bursal disease (IBD), as a highly infectious immunosuppressive disease, causes severe economic losses in the poultry industry worldwide. Saccharomyces cerevisiae is an appealing vehicle used in oral vaccine formulations to safely and effectively deliver heterologous antigens. It can elicit systemic and mucosal responses. This study aims...

Alternative Titles

Full title

Oral Immunization with Recombinant ISaccharomyces cerevisiae/I Expressing Viral Capsid Protein 2 of Infectious Bursal Disease Virus Induces Unique Specific Antibodies and Protective Immunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A779344915

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A779344915

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines11121849

How to access this item